Aspiration pneumonia and death in Huntington’s disease

Por Heemskerk, Anne-Wil, Roos, Raymund A.C.
Publicado em 2012

Current Pharmacological Approaches to Reduce Chorea in Huntington’s Disease

Por Coppen, Emma M., Roos, Raymund A. C.
Publicado no Drugs (2016)

Driving with a neurodegenerative disorder: an overview of the current literature

Por Jacobs, Milou, Hart, Ellen P., Roos, Raymund A. C.
Publicado no J Neurol (2017)

Cystathionine Levels in Patients With Huntington Disease

Por Aziz, N.A., Onkenhout, W., Kerstens, H.J., Roos, Raymund A.C.
Publicado no PLoS Curr (2015)

Seven-year clinical follow-up of premanifest carriers of Huntington's disease

Por Hart, Ellen, Middelkoop, Huub, Jurgens, Caroline K, Witjes-Ané, Marie-Noëlle W, Roos, Raymund A.C.
Publicado em 2011

β-Defensin Genomic Copy Number Does Not Influence the Age of Onset in Huntington’s Disease

Por Vittori, Angelica, Orth, Michael, Roos, Raymund A. C., Outeiro, Tiago F., Giorgini, Flaviano, Hollox, Edward J.
Publicado em 2013

The V471A Polymorphism in Autophagy-Related Gene ATG7 Modifies Age at Onset Specifically in Italian Huntington Disease Patients

Por Metzger, Silke, Walter, Carolin, Riess, Olaf, Roos, Raymund A. C., Nielsen, Jørgen E., Craufurd, David, Nguyen, Huu Phuc
Publicado em 2013

Early grey matter changes in structural covariance networks in Huntington's disease

Por Coppen, Emma M., van der Grond, Jeroen, Hafkemeijer, Anne, Rombouts, Serge A.R.B., Roos, Raymund A.C
Publicado no Neuroimage Clin (2016)

Copy-number variation of the neuronal glucose transporter gene SLC2A3 and age of onset in Huntington's disease

Por Vittori, Angelica, Breda, Carlo, Repici, Mariaelena, Orth, Michael, Roos, Raymund A.C., Outeiro, Tiago F., Giorgini, Flaviano, Hollox, Edward J.
Publicado em 2014

Dynamics of the connectome in Huntington's disease: A longitudinal diffusion MRI study

Por Odish, Omar F.F., Caeyenberghs, Karen, Hosseini, Hadi, van den Bogaard, Simon J.A., Roos, Raymund A.C., Leemans, Alexander
Publicado no Neuroimage Clin (2015)

MRI T2 Hypointensities in basal ganglia of premanifest Huntington's disease

Por Jurgens, Caroline K, Jasinschi, Radu, Ekin, Ahmet, Witjes-Ané, Marie-Noëlle W, van der Grond, Jeroen, Middelkoop, Huub, Roos, Raymund A.C.
Publicado em 2010

Delayed onset of the diurnal melatonin rise in patients with Huntington’s disease

Por Aziz, N. Ahmad, Pijl, Hanno, Frölich, Marijke, Schröder-van der Elst, Janny P., van der Bent, Chris, Roelfsema, Ferdinand, Roos, Raymund A. C.
Publicado em 2009

Magnetization transfer imaging in ‘premanifest’ Huntington’s disease

Por Jurgens, Caroline K., Bos, Reineke, Luyendijk, Jasper, Witjes-Ané, Marie-Noëlle W., van der Grond, Jeroen, Middelkoop, Huub A. M., Roos, Raymund A. C.
Publicado em 2009

Exploratory 7-Tesla magnetic resonance spectroscopy in Huntington’s disease provides in vivo evidence for impaired energy metabolism

Por van den Bogaard, Simon J. A., Dumas, Eve M., Teeuwisse, Wouter M., Kan, Hermien E., Webb, Andrew, Roos, Raymund A. C., van der Grond, Jeroen
Publicado em 2011

8OHdG is not a biomarker for Huntington disease state or progression

Por Borowsky, Beth, Warner, John, Leavitt, Blair R., Tabrizi, Sarah J., Roos, Raymund A.C., Durr, Alexandra, Becker, Chris, Sampaio, Cristina, Tobin, Allan J., Schulman, Howard
Publicado em 2013

NMDA receptor gene variations as modifiers in Huntington disease: a replication study

Por Saft, Carsten, Epplen, Jörg T., Wieczorek, Stefan, Landwehrmeyer, G. Bernhard, Roos, Raymund A.C., de Yebenes, Justo Garcia, Dose, Matthias, Tabrizi, Sarah J, Craufurd, David, Arning, Larissa
Publicado em 2011

Suprachiasmatic Nucleus Neuropeptide Expression in Patients with Huntington's Disease

Por van Wamelen, Daniel J., Aziz, N. Ahmad, Anink, Jasper J., van Steenhoven, Robin, Angeloni, Debora, Fraschini, Franco, Jockers, Ralf, Roos, Raymund A. C., Swaab, Dick F.
Publicado em 2013

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis

Por Byrne, Lauren M, Rodrigues, Filipe B, Blennow, Kaj, Durr, Alexandra, Leavitt, Blair R, Roos, Raymund A C, Scahill, Rachael I, Tabrizi, Sarah J, Zetterberg, Henrik, Langbehn, Douglas, Wild, Edward J
Publicado no Lancet Neurol (2017)

Evaluating multicenter DTI data in Huntington's disease on site specific effects: An ex post facto approach()

Por Müller, Hans-Peter, Grön, Georg, Sprengelmeyer, Reiner, Kassubek, Jan, Ludolph, Albert C., Hobbs, Nicola, Cole, James, Roos, Raymund A.C., Duerr, Alexandra, Tabrizi, Sarah J., Landwehrmeyer, G. Bernhard, Süssmuth, Sigurd D.
Publicado em 2013

Reduced functional brain connectivity prior to and after disease onset in Huntington's disease()()

Por Dumas, Eve M., van den Bogaard, Simon J.A., Hart, Ellen P., Soeter, Roelof P., van Buchem, Mark A., van der Grond, Jeroen, Rombouts, Serge A.R.B., Roos, Raymund A.C.
Publicado em 2013